Atrial fibrillation through the years: contemporary evaluation and management.
暂无分享,去创建一个
[1] M. Drazner,et al. 2013 ACCF/AHA guideline for the management of heart failure: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. , 2013, Journal of the American College of Cardiology.
[2] Gerhard Hindricks,et al. 2012 focused update of the ESC Guidelines for the management of atrial fibrillation: an update of the 2010 ESC Guidelines for the management of atrial fibrillation--developed with the special contribution of the European Heart Rhythm Association. , 2012, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.
[3] G. Lip,et al. Relation of the HAS-BLED Bleeding Risk Score to Major Bleeding, Cardiovascular Events, and Mortality in Anticoagulated Patients With Atrial Fibrillation , 2012, Circulation. Arrhythmia and electrophysiology.
[4] J. Dimarco,et al. Management of Atrial Fibrillation in Patients With Structural Heart Disease , 2012, Circulation.
[5] J. Burkhardt,et al. Examining the safety of amiodarone , 2012, Expert opinion on drug safety.
[6] C. Polanczyk,et al. Very Low Risk of Thromboembolic Events in Patients Undergoing Successful Catheter Ablation of Atrial Fibrillation With a CHADS2 Score ⩽3: A Long-Term Outcome Study , 2011, Circulation. Arrhythmia and electrophysiology.
[7] R. Hunter,et al. Maintenance of sinus rhythm with an ablation strategy in patients with atrial fibrillation is associated with a lower risk of stroke and death , 2011, Heart.
[8] David O. Martin,et al. Natural History and Long-Term Outcomes of Ablated Atrial Fibrillation , 2011, Circulation. Arrhythmia and electrophysiology.
[9] Silvia G Priori,et al. 2011 ACCF/AHA/HRS focused updates incorporated into the ACC/AHA/ESC 2006 guidelines for the management of patients with atrial fibrillation: a report of the American College of Cardiology Foundation/American Heart Association Task Force on practice guidelines. , 2011, Circulation.
[10] Kenneth A Ellenbogen,et al. 2011 ACCF/AHA/HRS focused update on the management of patients with atrial fibrillation (updating the 2006 guideline): a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. , 2011, Circulation.
[11] G. Lip,et al. Identifying Patients at High Risk for Stroke Despite Anticoagulation: A Comparison of Contemporary Stroke Risk Stratification Schemes in an Anticoagulated Atrial Fibrillation Cohort , 2010, Stroke.
[12] A. Chockalingam,et al. Tachycardia-Induced Cardiomyopathy : Evaluation and Therapeutic Options , 2010 .
[13] S. Themistoclakis,et al. The risk of thromboembolism and need for oral anticoagulation after successful atrial fibrillation ablation. , 2010, Journal of the American College of Cardiology.
[14] Burr Hall,et al. Comparison of antiarrhythmic drug therapy and radiofrequency catheter ablation in patients with paroxysmal atrial fibrillation: a randomized controlled trial. , 2010, JAMA.
[15] J. Brachmann,et al. Catheter Ablation versus Standard Conventional Treatment in Patients with Left Ventricular Dysfunction and Atrial Fibrillation (CASTLE‐AF) ‐ Study Design , 2009, Pacing and clinical electrophysiology : PACE.
[16] David O. Martin,et al. Pulmonary-vein isolation for atrial fibrillation in patients with heart failure. , 2008, The New England journal of medicine.
[17] A. Camm,et al. Rhythm Control versus Rate Control for Atrial Fibrillation and Heart Failure , 2009 .
[18] H. Collard,et al. A practical guide for clinicians who treat patients with amiodarone: 2007. , 2007, Heart rhythm.
[19] Mandeep Bhargava,et al. Radiofrequency ablation vs antiarrhythmic drugs as first-line treatment of symptomatic atrial fibrillation: a randomized trial. , 2005, JAMA.
[20] Gianni Tognoni,et al. Valsartan reduces the incidence of atrial fibrillation in patients with heart failure: results from the Valsartan Heart Failure Trial (Val-HeFT). , 2005, American heart journal.
[21] Prashanthan Sanders,et al. Catheter ablation for atrial fibrillation in congestive heart failure. , 2004, The New England journal of medicine.
[22] Christopher Piorkowski,et al. Late recurrent arrhythmias after ablation of atrial fibrillation: incidence, mechanisms, and treatment. , 2004, Heart rhythm.
[23] M. Domanski,et al. Relationships Between Sinus Rhythm, Treatment, and Survival in the Atrial Fibrillation Follow-Up Investigation of Rhythm Management (AFFIRM) Study , 2004, Circulation.
[24] H. Crijns,et al. A comparison of rate control and rhythm control in patients with recurrent persistent atrial fibrillation. , 2002, The New England journal of medicine.
[25] A L Waldo,et al. A comparison of rate control and rhythm control in patients with atrial fibrillation. , 2002, The New England journal of medicine.
[26] H. Crijns,et al. A comparison of rate control and rhythm control in patients with recurrent persistent atrial fibrillation , 2002 .
[27] M. Rich,et al. Validation of clinical classification schemes for predicting stroke: results from the National Registry of Atrial Fibrillation. , 2001, JAMA.
[28] G. Kay,et al. Tachycardia-related cardiomyopathy: a common cause of ventricular dysfunction in patients with atrial fibrillation referred for atrioventricular ablation. , 2000, Mayo Clinic proceedings.
[29] B. Lewis,et al. Identifying patients at high risk for restenosis after percutaneous transluminal coronary angioplasty for unstable angina pectoris. , 1989, The American journal of cardiology.
[30] A. Wear. CIRCULATION , 1964, The Lancet.
[31] José Jalife,et al. 2017 HRS/EHRA/ECAS/APHRS/SOLAECE expert consensus statement on catheter and surgical ablation of atrial fibrillation , 2012, Heart rhythm.
[32] William T. Abraham,et al. Focused Update : ACCF / AHA Guidelines for the Diagnosis and Management of Heart Failure in Adults , 2013 .
[33] S. Mouly,et al. Antiarrhythmics for maintaining sinus rhythm after cardioversion of atrial fibrillation. , 2007, The Cochrane database of systematic reviews.
[34] A. Waldo. Radiofrequency Ablation vs Antiarrhythmic Drugs as First-line Treatment of Symptomatic Atrial Fibrillation: A Randomized Trial , 2006 .
[35] Wolters Kluwer,et al. Hrs/ehra/ecas Expert Consensus Statement on Catheter and Surgical Ablation of Atrial Fibrillation: Recommendations for Patient Selection, Procedural Techniques, Patient Management and Follow-up, Definitions, Endpoints, and Research Trial Design: a Report of the Heart Rhythm Society (hrs) Task Force , 2022 .